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Supplementary Data S1. Top 200 transcripts and protein genes with the highest measured gene expression in FPKM in the studied pregnancy outcomes (a separate .xls file). Gene set enrichment analysis of identified genes with significant differential expression was performed using g:Profiler 8 . Enrichment was tested for categories related to Gene Ontology, KEGG pathways and transcription factor (TF) regulatory motifs. Statistical testing, principal component analysis (PCA) and hierarchical clustering (Pearson correlation as the distance function) was performed in R. To achieve s scaled expression value (Z-score), the gene expression levels were subjected to variance stabilizing transformation in DESeq and standardized by subtracting the mean expression across all samples from its value for a given sample and then dividing by the standard deviation across all the samples. Data on the enrichment of gene expression in the placenta compared to other tissues was derived from the publicly available Protein Atlas v12 database reporting RNA-Seq analysis across 27 human tissues 9 .
The statistical analyses for RT-qPCR results were performed using statistical package STATA .
Taqman RT-qPCR
For an independent experimental validation, gene expression of 48 protein-encoding genes and a non-coding transcript ITPK1-AS (belonging to sense-antisense pair with ITPK1) was analyzed using Taqman RT-qPCR gene expression assays (Applied Biosystems, Life Technologies;
Supplementary Table S5 ). Majority of the assessed genes (n=43) were selected from the top-list of differential expression in PE and two genes (STS, FAM65B) due to significantly altered expression in GD compared to NORM (DESeq: FDR<0.1 and DESeq2: FDR<0.05;
Supplementary Data S3). Genes with unavailable pre-designed Taqman assay or low placental expression (< 100 normalized read count) were not subjected to validation. As no genes from the analysis of LGA vs NORM and SGA vs NORM satisfied the criteria to be selected to Taqman RT-qPCR validation, alternative differential expression tests among the study groups were performed (data not shown). Three additional genes showing trend for altered expression were taken forward to Taqman RT-qPCR: SLC16A3 (GD vs LGA) and MYO7B, TET3 (SGA vs LGA samples). All genes analyzed for the differential placental expression in PE (n=45) were also assessed in SGA samples; all genes tested in GD placentas (n=5) were also analyzed in the LGA group (Supplementary Table S5 ).
Gene expression was quantitated by singleplex RT-qPCR of the target gene sequence using PE, preeclampsia, GD, gestational diabetes, SGA and LGA, small-and large-for-gestational-age newborns, IUGR -intrauterine growth restriction. 
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